IDEAYA Biosciences, Inc.
IDYA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001676725
In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in IDEAYA Biosciences, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 206
- −1 vs. Q3 2024
- Shares held
- 92.0M
- +86.3K (+0.1%) vs. Q3 2024
- Total value
- $2.36B
- −$547.1M (−18.8%) vs. Q3 2024
- New holders
- 34
- 94 more added
- Sold out
- 35
- 56 more reduced
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IDYA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 285 | $3.80B |
| Q1 2026 | 254 | $3.16B |
| Q4 2025 | 246 | $3.32B |
| Q3 2025 | 224 | $2.56B |
| Q2 2025 | 204 | $2.04B |
| Q1 2025 | 207 | $1.54B |
| Q4 2024 | 206 | $2.36B |
| Q3 2024 | 209 | $2.91B |
| Q2 2024 | 199 | $2.90B |
| Q1 2024 | 204 | $3.47B |
| Q4 2023 | 157 | $2.35B |
| Q3 2023 | 144 | $1.61B |
| Q2 2023 | 138 | $1.33B |
| Q1 2023 | 128 | $625.4M |
| Q4 2022 | 117 | $835.0M |
| Q3 2022 | 112 | $667.1M |
| Q2 2022 | 96 | $489.0M |
| Q1 2022 | 103 | $392.9M |
| Q4 2021 | 110 | $820.7M |
| Q3 2021 | 91 | $837.9M |
| Q2 2021 | 84 | $533.4M |
| Q1 2021 | 89 | $558.6M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding IDEAYA Biosciences, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Price T Rowe Associates Inc | 3,866,908 | $99.4M | 0.01% | −148,390−3.7% | Reduced |
| Federated Hermes, Inc. | 5,063,526 | $130.1M | 0.29% | −144,774−2.8% | Reduced |
| Vanguard Group Inc | 5,078,084 | $130.5M | 0.00% | +282,936+5.9% | Added |
| Janus Henderson Group PLC | 5,857,639 | $150.6M | 0.08% | +695,263+13.5% | Added |
| BlackRock, Inc. | 8,377,056 | $215.3M | 0.00% | +696,115+9.1% | Added |
| FMR LLC | 12,963,151 | $333.2M | 0.02% | +327,498+2.6% | Added |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −2,202,812−100.0% | Sold out |
| BVF Inc | 0 | $0 | 0.00% | −1,409,993−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −1,049,314−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −638,884−100.0% | Sold out |
| Holocene Advisors, LP | 0 | $0 | 0.00% | −562,848−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −175,000−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −132,703−100.0% | Sold out |
| Artia Global Partners LP | 0 | $0 | 0.00% | −62,992−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −52,865−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −50,370−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Nicholas Investment Partners, LP | 0 | $0 | 0.00% | −29,625−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −21,678−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −20,405−100.0% | Sold out |
| Readystate Asset Management LP | 0 | $0 | 0.00% | −16,423−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −12,686−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −12,400−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −8,839−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −8,674−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −7,720−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −7,605−100.0% | Sold out |
| Bellevue Group AG | 0 | $0 | 0.00% | −7,200−100.0% | Sold out |
| Callan Capital, LLC | 0 | $0 | 0.00% | −6,726−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −6,708−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −4,405−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −2,627−100.0% | Sold out |
| Values First Advisors, Inc. | 0 | $0 | 0.00% | −2,345−100.0% | Sold out |
| Ci Investments Inc. | 0 | $0 | 0.00% | −1,799−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Wolff Wiese Magana LLC | 0 | $0 | 0.00% | −140−100.0% | Sold out |
| Park Place Capital Corp | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Chartwell Investment Partners, LLC | – | – | – | – | Not filed |
| Halpern Financial, Inc. | – | – | – | – | Not filed |